Equities Research Analysts’ price target changes for Thursday, November 13th:
Absci (NASDAQ:ABSI) had its target price lowered by Needham & Company LLC from $8.00 to $7.00. They currently have a buy rating on the stock.
ACG Acquisition (LON:ACG) had its price target boosted by Canaccord Genuity Group Inc. from GBX 1,230 to GBX 1,500. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
American Healthcare REIT (NYSE:AHR) had its target price raised by KeyCorp from $43.00 to $55.00. The firm currently has an overweight rating on the stock.
American Healthcare REIT (NYSE:AHR) had its price target raised by Scotiabank from $47.00 to $55.00. Scotiabank currently has a sector outperform rating on the stock.
Airgain (NASDAQ:AIRG) had its price target trimmed by Craig Hallum from $7.00 to $5.00. The firm currently has a buy rating on the stock.
Akamai Technologies (NASDAQ:AKAM) had its target price increased by TD Cowen from $98.00 to $104.00. TD Cowen currently has a hold rating on the stock.
Albemarle (NYSE:ALB) had its target price increased by Mizuho from $92.00 to $110.00. Mizuho currently has a neutral rating on the stock.
Albemarle (NYSE:ALB) had its price target increased by UBS Group AG from $85.00 to $107.00. UBS Group AG currently has a neutral rating on the stock.
Alkermes (NASDAQ:ALKS) had its target price cut by Deutsche Bank Aktiengesellschaft from $55.00 to $45.00. The firm currently has a buy rating on the stock.
Alkermes (NASDAQ:ALKS) had its price target trimmed by Wells Fargo & Company from $42.00 to $37.00. They currently have an overweight rating on the stock.
Almonty Industries (NASDAQ:ALM) had its target price boosted by DA Davidson from $11.00 to $12.00. They currently have a buy rating on the stock.
American Homes 4 Rent (NYSE:AMH) had its target price cut by Morgan Stanley from $41.00 to $40.00. The firm currently has an overweight rating on the stock.
Ameriprise Financial (NYSE:AMP) had its target price lowered by Argus from $568.00 to $554.00. Argus currently has a buy rating on the stock.
Abercrombie & Fitch (NYSE:ANF) had its price target lowered by UBS Group AG from $130.00 to $125.00. UBS Group AG currently has a buy rating on the stock.
Alto Neuroscience (NYSE:ANRO) had its price target increased by Robert W. Baird from $16.00 to $22.00. Robert W. Baird currently has an outperform rating on the stock.
Ardent Health (NYSE:ARDT) had its target price lowered by Bank of America Corporation from $12.00 to $10.00. Bank of America Corporation currently has an underperform rating on the stock.
AvalonBay Communities (NYSE:AVB) had its target price lowered by Morgan Stanley from $225.00 to $222.50. Morgan Stanley currently has an overweight rating on the stock.
Bain Capital Specialty Finance (NYSE:BCSF) had its price target lowered by Keefe, Bruyette & Woods from $17.00 to $16.00. Keefe, Bruyette & Woods currently has a market perform rating on the stock.
Broadridge Financial Solutions (NYSE:BR) had its target price lowered by UBS Group AG from $280.00 to $250.00. They currently have a neutral rating on the stock.
BellRing Brands (NYSE:BRBR) had its price target trimmed by TD Cowen from $45.00 to $37.00. TD Cowen currently has a buy rating on the stock.
Brixmor Property Group (NYSE:BRX) had its price target trimmed by Scotiabank from $31.00 to $30.00. They currently have a sector outperform rating on the stock.
Brainsway (NASDAQ:BWAY) had its target price increased by HC Wainwright from $17.00 to $18.00. They currently have a buy rating on the stock.
BWX Technologies (NYSE:BWXT) had its price target increased by Bank of America Corporation from $220.00 to $230.00. The firm currently has a buy rating on the stock.
BXP (NYSE:BXP) had its price target increased by Scotiabank from $77.00 to $81.00. The firm currently has a sector perform rating on the stock.
Beyond Meat (NASDAQ:BYND) had its price target reduced by Mizuho from $1.50 to $1.00. They currently have an underperform rating on the stock.
CAE (NYSE:CAE) (TSE:CAE) had its target price trimmed by Royal Bank Of Canada from $41.00 to $40.00. Royal Bank Of Canada currently has a sector perform rating on the stock.
CAVA Group (NYSE:CAVA) had its price target trimmed by Argus from $76.00 to $60.00. They currently have a buy rating on the stock.
Cameco (NYSE:CCJ) (TSE:CCO) had its price target reduced by Royal Bank Of Canada from $160.00 to $150.00. The firm currently has an outperform rating on the stock.
Cogent Communications (NASDAQ:CCOI) had its price target reduced by Royal Bank Of Canada from $40.00 to $23.00. They currently have a sector perform rating on the stock.
Cogent Communications (NASDAQ:CCOI) had its price target lowered by JPMorgan Chase & Co. from $37.00 to $23.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Celcuity (NASDAQ:CELC) had its price target boosted by Craig Hallum from $96.00 to $108.00. Craig Hallum currently has a buy rating on the stock.
Celcuity (NASDAQ:CELC) had its target price increased by Stifel Nicolaus from $68.00 to $115.00. Stifel Nicolaus currently has a buy rating on the stock.
CI&T (NYSE:CINT) had its target price reduced by JPMorgan Chase & Co. from $8.00 to $7.00. They currently have an overweight rating on the stock.
Cellebrite DI (NASDAQ:CLBT) had its price target increased by Bank of America Corporation from $24.00 to $25.00. The firm currently has a buy rating on the stock.
Cellebrite DI (NASDAQ:CLBT) had its target price increased by Lake Street Capital from $22.00 to $23.00. They currently have a buy rating on the stock.
Cellebrite DI (NASDAQ:CLBT) had its price target increased by JPMorgan Chase & Co. from $23.00 to $24.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Cellebrite DI (NASDAQ:CLBT) had its target price raised by Needham & Company LLC from $22.00 to $24.00. Needham & Company LLC currently has a buy rating on the stock.
Comcast (NASDAQ:CMCSA) had its target price lowered by Moffett Nathanson from $58.00 to $53.00. They currently have a buy rating on the stock.
CME Group (NASDAQ:CME) had its price target raised by Piper Sandler from $296.00 to $313.00. They currently have an overweight rating on the stock.
CNH Industrial (NYSE:CNH) had its price target cut by UBS Group AG from $16.00 to $15.00. UBS Group AG currently has a buy rating on the stock.
Centessa Pharmaceuticals (NASDAQ:CNTA) had its price target increased by Wells Fargo & Company from $30.00 to $35.00. They currently have an overweight rating on the stock.
Cogent Biosciences (NASDAQ:COGT) had its target price increased by HC Wainwright from $21.00 to $50.00. The firm currently has a buy rating on the stock.
Coya Therapeutics (NASDAQ:COYA) had its price target increased by BTIG Research from $15.00 to $16.00. They currently have a buy rating on the stock.
Camden Property Trust (NYSE:CPT) had its target price lowered by Morgan Stanley from $124.00 to $123.00. The firm currently has an equal weight rating on the stock.
Corbus Pharmaceuticals (NASDAQ:CRBP) had its target price reduced by Royal Bank Of Canada from $55.00 to $53.00. Royal Bank Of Canada currently has an outperform rating on the stock.
Circle Internet Group (NYSE:CRCL) had its target price cut by Wells Fargo & Company from $160.00 to $128.00. The firm currently has an overweight rating on the stock.
Circle Internet Group (NYSE:CRCL) had its target price cut by Deutsche Bank Aktiengesellschaft from $147.00 to $90.00. They currently have a hold rating on the stock.
Circle Internet Group (NYSE:CRCL) had its price target trimmed by Robert W. Baird from $144.00 to $110.00. Robert W. Baird currently has a neutral rating on the stock.
Circle Internet Group (NYSE:CRCL) had its price target reduced by Needham & Company LLC from $250.00 to $190.00. Needham & Company LLC currently has a buy rating on the stock.
CorMedix (NASDAQ:CRMD) had its target price increased by HC Wainwright from $17.00 to $18.00. HC Wainwright currently has a buy rating on the stock.
CrowdStrike (NASDAQ:CRWD) had its price target increased by Morgan Stanley from $475.00 to $515.00. Morgan Stanley currently has an equal weight rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its target price increased by KeyCorp from $77.00 to $87.00. They currently have an overweight rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its price target raised by Wells Fargo & Company from $83.00 to $95.00. They currently have an overweight rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its price target boosted by JPMorgan Chase & Co. from $80.00 to $90.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its price target raised by Evercore ISI from $74.00 to $80.00. The firm currently has an in-line rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its target price increased by Morgan Stanley from $77.00 to $82.00. Morgan Stanley currently has an overweight rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its target price increased by Rosenblatt Securities from $87.00 to $100.00. Rosenblatt Securities currently has a buy rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its price target raised by Bank of America Corporation from $85.00 to $95.00. Bank of America Corporation currently has a buy rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its price target increased by Melius Research from $84.00 to $100.00. Melius Research currently has a buy rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its price target increased by UBS Group AG from $88.00 to $90.00. The firm currently has a buy rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its price target increased by Piper Sandler from $70.00 to $86.00. They currently have a neutral rating on the stock.
Centuri (NYSE:CTRI) had its price target increased by UBS Group AG from $22.00 to $24.00. They currently have a neutral rating on the stock.
CVS Health (NYSE:CVS) had its price target trimmed by Wells Fargo & Company from $103.00 to $102.00. They currently have an overweight rating on the stock.
Chevron (NYSE:CVX) had its target price increased by Morgan Stanley from $177.00 to $180.00. Morgan Stanley currently has an overweight rating on the stock.
Chevron (NYSE:CVX) had its price target boosted by Mizuho from $191.00 to $204.00. The firm currently has an outperform rating on the stock.
Endava (NYSE:DAVA) had its price target lowered by Morgan Stanley from $11.00 to $8.00. They currently have an equal weight rating on the stock.
Digi International (NASDAQ:DGII) had its price target raised by Piper Sandler from $36.00 to $41.00. They currently have a neutral rating on the stock.
Digi International (NASDAQ:DGII) had its target price increased by Roth Capital from $45.00 to $50.00. The firm currently has a buy rating on the stock.
Digi International (NASDAQ:DGII) had its target price increased by B. Riley from $45.00 to $48.00. The firm currently has a buy rating on the stock.
DraftKings (NASDAQ:DKNG) had its price target cut by Mizuho from $54.00 to $46.00. They currently have an outperform rating on the stock.
Draganfly (NASDAQ:DPRO) had its target price lowered by Needham & Company LLC from $20.00 to $14.00. They currently have a buy rating on the stock.
Enlight Renewable Energy (NASDAQ:ENLT) had its target price boosted by Roth Capital from $30.00 to $45.00. Roth Capital currently has a buy rating on the stock.
Equity Residential (NYSE:EQR) had its target price cut by Morgan Stanley from $75.00 to $73.50. Morgan Stanley currently has an equal weight rating on the stock.
Energy Transfer (NYSE:ET) had its target price lowered by Scotiabank from $23.00 to $21.00. Scotiabank currently has a sector outperform rating on the stock.
Endeavour Silver (NYSE:EXK) (TSE:EDR) had its target price increased by B. Riley from $7.00 to $11.00. The firm currently has a buy rating on the stock.
Fastenal (NASDAQ:FAST) had its target price trimmed by Barclays PLC from $45.00 to $44.00. Barclays PLC currently has an equal weight rating on the stock.
FedEx (NYSE:FDX) had its target price increased by Bank of America Corporation from $270.00 to $285.00. They currently have a neutral rating on the stock.
FIGS (NYSE:FIGS) had its target price boosted by BTIG Research from $10.00 to $12.00. The firm currently has a buy rating on the stock.
Fidelis Insurance (NYSE:FIHL) had its target price increased by Evercore ISI from $19.00 to $20.00. Evercore ISI currently has an in-line rating on the stock.
Fluence Energy (NASDAQ:FLNC) had its price target boosted by Roth Capital from $7.00 to $17.00. The firm currently has a neutral rating on the stock.
Flowers Foods (NYSE:FLO) had its target price lowered by Truist Financial Corporation from $15.00 to $10.00. The firm currently has a hold rating on the stock.
Fluor (NYSE:FLR) had its target price lowered by UBS Group AG from $56.00 to $52.00. They currently have a buy rating on the stock.
Flutter Entertainment (NYSE:FLUT) had its price target trimmed by Stifel Nicolaus from $339.00 to $330.00. Stifel Nicolaus currently has a buy rating on the stock.
Flutter Entertainment (NYSE:FLUT) had its target price cut by Needham & Company LLC from $325.00 to $300.00. They currently have a buy rating on the stock.
Flutter Entertainment (NYSE:FLUT) had its target price cut by BTIG Research from $321.00 to $271.00. They currently have a buy rating on the stock.
Flutter Entertainment (NYSE:FLUT) had its target price lowered by Truist Financial Corporation from $335.00 to $305.00. They currently have a buy rating on the stock.
Flutter Entertainment (NYSE:FLUT) had its price target raised by Citizens Jmp from $340.00 to $345.00. The firm currently has a market outperform rating on the stock.
Firefly Aerospace (NASDAQ:FLY) had its price target cut by Roth Capital from $40.00 to $30.00. Roth Capital currently has a buy rating on the stock.
Flywire (NASDAQ:FLYW) had its target price boosted by Truist Financial Corporation from $15.00 to $16.00. Truist Financial Corporation currently has a buy rating on the stock.
First Solar (NASDAQ:FSLR) had its price target increased by Rothschild & Co Redburn from $150.00 to $260.00. Rothschild & Co Redburn currently has a neutral rating on the stock.
FTC Solar (NASDAQ:FTCI) had its target price increased by TD Cowen from $8.00 to $12.50. TD Cowen currently has a buy rating on the stock.
GCT Semiconductor (NYSE:GCTS) had its target price cut by B. Riley from $4.50 to $4.00. B. Riley currently has a buy rating on the stock.
GlobalFoundries (NASDAQ:GFS) had its price target reduced by JPMorgan Chase & Co. from $40.00 to $35.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
GlobalFoundries (NASDAQ:GFS) had its target price increased by Wedbush from $40.00 to $42.00. Wedbush currently has an outperform rating on the stock.
GlobalFoundries (NASDAQ:GFS) had its price target raised by Evercore ISI from $43.00 to $45.00. They currently have an outperform rating on the stock.
Gilead Sciences (NASDAQ:GILD) had its target price boosted by Daiwa Capital Markets from $128.00 to $129.00. The firm currently has an outperform rating on the stock.
Gilead Sciences (NASDAQ:GILD) had its price target raised by Needham & Company LLC from $133.00 to $140.00. Needham & Company LLC currently has a buy rating on the stock.
Gilat Satellite Networks (NASDAQ:GILT) had its target price increased by Needham & Company LLC from $11.00 to $16.00. The firm currently has a buy rating on the stock.
Global Payments (NYSE:GPN) had its price target lowered by Truist Financial Corporation from $90.00 to $84.00. The firm currently has a hold rating on the stock.
HCA Healthcare (NYSE:HCA) had its price target boosted by Wells Fargo & Company from $412.00 to $431.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Harley-Davidson (NYSE:HOG) had its price target cut by UBS Group AG from $28.00 to $27.00. UBS Group AG currently has a neutral rating on the stock.
Heartflow (NASDAQ:HTFL) had its target price boosted by JPMorgan Chase & Co. from $36.00 to $40.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Heartflow (NASDAQ:HTFL) had its target price boosted by Stifel Nicolaus from $35.00 to $40.00. They currently have a buy rating on the stock.
Helios Towers (LON:HTWS) had its target price increased by Berenberg Bank from GBX 175 to GBX 215. Berenberg Bank currently has a buy rating on the stock.
Humacyte (NASDAQ:HUMA) had its target price lowered by Benchmark Co. from $14.00 to $11.00. The firm currently has a buy rating on the stock.
Ibotta (NYSE:IBTA) had its target price lowered by Evercore ISI from $38.00 to $32.00. They currently have an in-line rating on the stock.
Ibotta (NYSE:IBTA) had its target price reduced by Bank of America Corporation from $24.00 to $22.00. The firm currently has an underperform rating on the stock.
Ibotta (NYSE:IBTA) had its price target trimmed by The Goldman Sachs Group, Inc. from $26.00 to $23.00. The firm currently has a sell rating on the stock.
Intellicheck (NYSE:IDN) had its target price boosted by DA Davidson from $6.50 to $7.50. They currently have a neutral rating on the stock.
iHeartMedia (NASDAQ:IHRT) had its price target increased by Bank of America Corporation from $3.00 to $5.00. The firm currently has a neutral rating on the stock.
Immunic (NASDAQ:IMUX) had its price target reduced by D. Boral Capital from $10.00 to $8.00. They currently have a buy rating on the stock.
Invitation Home (NYSE:INVH) had its price target lowered by Morgan Stanley from $35.00 to $34.00. Morgan Stanley currently has an equal weight rating on the stock.
Kayne Anderson BDC (NYSE:KBDC) had its target price reduced by Keefe, Bruyette & Woods from $16.50 to $16.00. The firm currently has an outperform rating on the stock.
KBR (NYSE:KBR) had its target price trimmed by Bank of America Corporation from $55.00 to $45.00. The firm currently has a neutral rating on the stock.
Kimco Realty (NYSE:KIM) had its target price lowered by Scotiabank from $23.00 to $22.00. Scotiabank currently has a sector perform rating on the stock.
Kinder Morgan (NYSE:KMI) had its target price raised by Royal Bank Of Canada from $28.00 to $30.00. The firm currently has a sector perform rating on the stock.
Kennametal (NYSE:KMT) had its target price increased by UBS Group AG from $21.00 to $28.00. UBS Group AG currently has a neutral rating on the stock.
Kinetik (NYSE:KNTK) had its target price trimmed by Scotiabank from $51.00 to $45.00. Scotiabank currently has a sector outperform rating on the stock.
Kopin (NASDAQ:KOPN) had its price target increased by Lake Street Capital from $3.00 to $4.00. They currently have a buy rating on the stock.
KORE Group (NYSE:KORE) had its price target raised by TD Cowen from $3.00 to $5.00. They currently have a hold rating on the stock.
Legend Biotech (NASDAQ:LEGN) had its target price boosted by Cantor Fitzgerald from $66.00 to $75.00. The firm currently has an overweight rating on the stock.
Legend Biotech (NASDAQ:LEGN) had its price target reduced by Royal Bank Of Canada from $75.00 to $74.00. They currently have an outperform rating on the stock.
Largo (NYSE:LGO) had its target price trimmed by HC Wainwright from $3.70 to $2.90. The firm currently has a buy rating on the stock.
LivaNova (NASDAQ:LIVN) had its target price increased by Mizuho from $65.00 to $70.00. The firm currently has an outperform rating on the stock.
LivaNova (NASDAQ:LIVN) had its price target boosted by Robert W. Baird from $63.00 to $70.00. The firm currently has an outperform rating on the stock.
Eli Lilly and Company (NYSE:LLY) had its target price increased by Morgan Stanley from $1,090.00 to $1,171.00. They currently have an overweight rating on the stock.
Cheniere Energy (NYSE:LNG) had its price target lowered by Scotiabank from $261.00 to $257.00. They currently have a sector outperform rating on the stock.
Loar (NYSE:LOAR) had its price target trimmed by Morgan Stanley from $100.00 to $97.00. The firm currently has an overweight rating on the stock.
Lords Group Trading (LON:LORD) had its target price reduced by Berenberg Bank from GBX 80 to GBX 65. Berenberg Bank currently has a buy rating on the stock.
Lipocine (NASDAQ:LPCN) had its price target lowered by HC Wainwright from $8.00 to $7.00. The firm currently has a buy rating on the stock.
LegalZoom.com (NASDAQ:LZ) had its target price boosted by Morgan Stanley from $8.50 to $9.00. Morgan Stanley currently has an underweight rating on the stock.
Mid-America Apartment Communities (NYSE:MAA) had its price target trimmed by Morgan Stanley from $169.00 to $164.00. They currently have an overweight rating on the stock.
Macerich (NYSE:MAC) had its target price boosted by Scotiabank from $18.00 to $19.00. They currently have a sector perform rating on the stock.
Medtronic (NYSE:MDT) had its price target boosted by JPMorgan Chase & Co. from $90.00 to $100.00. The firm currently has a neutral rating on the stock.
MDxHealth (NASDAQ:MDXH) had its price target raised by Lake Street Capital from $7.00 to $9.00. The firm currently has a buy rating on the stock.
MDxHealth (NASDAQ:MDXH) had its price target raised by TD Cowen from $5.00 to $7.00. TD Cowen currently has a buy rating on the stock.
MDxHealth (NASDAQ:MDXH) had its price target increased by BTIG Research from $6.00 to $7.00. The firm currently has a buy rating on the stock.
McGraw Hill (NYSE:MH) had its price target boosted by UBS Group AG from $15.00 to $16.00. They currently have a neutral rating on the stock.
McGraw Hill (NYSE:MH) had its target price lowered by BMO Capital Markets from $25.00 to $21.00. The firm currently has an outperform rating on the stock.
Micron Technology (NASDAQ:MU) had its price target boosted by Morgan Stanley from $220.00 to $325.00. Morgan Stanley currently has an overweight rating on the stock.
National Energy Services Reunited (NASDAQ:NESR) had its price target increased by BTIG Research from $12.00 to $16.00. They currently have a buy rating on the stock.
Nexxen International (NASDAQ:NEXN) had its target price cut by BTIG Research from $13.00 to $10.00. They currently have a buy rating on the stock.
Nexxen International (NASDAQ:NEXN) had its target price trimmed by Needham & Company LLC from $14.00 to $9.00. Needham & Company LLC currently has a buy rating on the stock.
Neurogene (NASDAQ:NGNE) had its price target boosted by HC Wainwright from $65.00 to $70.00. The firm currently has a buy rating on the stock.
Neptune Insurance (NYSE:NP) had its target price boosted by Bank of America Corporation from $21.00 to $22.50. They currently have an underperform rating on the stock.
Neptune Insurance (NYSE:NP) had its target price raised by Mizuho from $23.00 to $26.00. They currently have an underperform rating on the stock.
Natera (NASDAQ:NTRA) had its price target increased by Stephens from $197.00 to $235.00. The firm currently has an overweight rating on the stock.
NVIDIA (NASDAQ:NVDA) had its price target boosted by Oppenheimer Holdings, Inc. from $225.00 to $265.00. Oppenheimer Holdings, Inc. currently has an outperform rating on the stock.
NVIDIA (NASDAQ:NVDA) had its target price increased by Susquehanna from $210.00 to $230.00. The firm currently has a positive rating on the stock.
News (NASDAQ:NWSA) had its target price reduced by Guggenheim from $45.00 to $43.00. The firm currently has a buy rating on the stock.
Nextracker (NASDAQ:NXT) had its target price boosted by Royal Bank Of Canada from $93.00 to $96.00. Royal Bank Of Canada currently has an outperform rating on the stock.
Oculis (NASDAQ:OCS) had its price target cut by Bank of America Corporation from $30.00 to $29.00. Bank of America Corporation currently has a buy rating on the stock.
Omega Healthcare Investors (NYSE:OHI) had its target price boosted by Scotiabank from $42.00 to $45.00. Scotiabank currently has a sector perform rating on the stock.
Ondas (NASDAQ:ONDS) had its price target increased by Needham & Company LLC from $9.00 to $10.00. They currently have a buy rating on the stock.
ON (NYSE:ONON) had its price target increased by JPMorgan Chase & Co. from $71.00 to $75.00. The firm currently has an overweight rating on the stock.
ON (NYSE:ONON) had its target price increased by TD Cowen from $55.00 to $57.00. TD Cowen currently has a buy rating on the stock.
ON (NYSE:ONON) had its target price increased by UBS Group AG from $79.00 to $85.00. The firm currently has a buy rating on the stock.
ON (NYSE:ONON) had its target price raised by Morgan Stanley from $65.00 to $70.00. Morgan Stanley currently has an overweight rating on the stock.
ON (NYSE:ONON) had its target price raised by Bank of America Corporation from $62.00 to $63.00. They currently have a buy rating on the stock.
ON (NYSE:ONON) had its target price raised by The Goldman Sachs Group, Inc. from $50.00 to $52.00. They currently have a neutral rating on the stock.
Oruka Therapeutics (NASDAQ:ORKA) had its price target boosted by BTIG Research from $56.00 to $63.00. The firm currently has a buy rating on the stock.
Oscar Health (NYSE:OSCR) had its price target cut by Wells Fargo & Company from $14.00 to $11.00. The firm currently has an underweight rating on the stock.
Occidental Petroleum (NYSE:OXY) had its price target increased by Susquehanna from $54.00 to $55.00. They currently have a positive rating on the stock.
Plains All American Pipeline (NYSE:PAA) had its target price reduced by Scotiabank from $20.00 to $19.00. The firm currently has a sector outperform rating on the stock.
Palo Alto Networks (NASDAQ:PANW) had its price target boosted by UBS Group AG from $200.00 to $230.00. The firm currently has a neutral rating on the stock.
Palo Alto Networks (NASDAQ:PANW) had its target price boosted by Evercore ISI from $220.00 to $250.00. Evercore ISI currently has an outperform rating on the stock.
Palo Alto Networks (NASDAQ:PANW) had its target price raised by Morgan Stanley from $216.00 to $228.00. The firm currently has an overweight rating on the stock.
Palo Alto Networks (NASDAQ:PANW) had its price target boosted by TD Cowen from $230.00 to $255.00. They currently have a buy rating on the stock.
PDS Biotechnology (NASDAQ:PDSB) had its price target boosted by HC Wainwright from $13.00 to $15.00. The firm currently has a buy rating on the stock.
PepGen (NASDAQ:PEPG) had its price target raised by HC Wainwright from $18.00 to $20.00. HC Wainwright currently has a buy rating on the stock.
Perion Network (NASDAQ:PERI) had its target price boosted by Lake Street Capital from $14.00 to $15.00. Lake Street Capital currently has a buy rating on the stock.
Pharvaris (NASDAQ:PHVS) had its price target increased by Wedbush from $27.00 to $30.00. Wedbush currently has an outperform rating on the stock.
PPHE Hotel Group (LON:PPH) had its target price boosted by Jefferies Financial Group Inc. from GBX 1,600 to GBX 1,920. Jefferies Financial Group Inc. currently has a buy rating on the stock.
Praxis Precision Medicines (NASDAQ:PRAX) had its price target boosted by HC Wainwright from $232.00 to $258.00. They currently have a buy rating on the stock.
Privia Health Group (NASDAQ:PRVA) had its target price increased by JPMorgan Chase & Co. from $32.00 to $33.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
PolyPid (NASDAQ:PYPD) had its price target lowered by Roth Capital from $10.00 to $9.00. They currently have a buy rating on the stock.
LiveRamp (NYSE:RAMP) had its target price raised by Morgan Stanley from $30.00 to $33.00. The firm currently has an equal weight rating on the stock.
Regency Centers (NASDAQ:REG) had its target price raised by Scotiabank from $76.00 to $78.00. Scotiabank currently has a sector perform rating on the stock.
Rockwell Medical (NASDAQ:RMTI) had its price target lowered by HC Wainwright from $3.00 to $2.50. The firm currently has a buy rating on the stock.
Riskified (NYSE:RSKD) had its price target increased by UBS Group AG from $5.00 to $5.50. The firm currently has a neutral rating on the stock.
Sinclair (NASDAQ:SBGI) had its target price raised by Guggenheim from $19.00 to $20.00. Guggenheim currently has a buy rating on the stock.
Surgery Partners (NASDAQ:SGRY) had its target price reduced by UBS Group AG from $34.00 to $29.00. They currently have a buy rating on the stock.
Simon Property Group (NYSE:SPG) had its price target boosted by Scotiabank from $173.00 to $186.00. The firm currently has a sector perform rating on the stock.
Sprout Social (NASDAQ:SPT) had its target price cut by Morgan Stanley from $17.00 to $14.00. They currently have an equal weight rating on the stock.
SoundThinking (NASDAQ:SSTI) had its price target trimmed by Cantor Fitzgerald from $20.00 to $16.00. Cantor Fitzgerald currently has an overweight rating on the stock.
SoundThinking (NASDAQ:SSTI) had its target price trimmed by Citizens Jmp from $19.00 to $16.00. Citizens Jmp currently has a market outperform rating on the stock.
SoundThinking (NASDAQ:SSTI) had its price target cut by Lake Street Capital from $19.00 to $14.00. Lake Street Capital currently has a buy rating on the stock.
Savara (NASDAQ:SVRA) had its price target trimmed by Citizens Jmp from $11.00 to $10.00. Citizens Jmp currently has a market outperform rating on the stock.
TScan Therapeutics (NASDAQ:TCRX) had its price target cut by HC Wainwright from $10.00 to $7.00. They currently have a buy rating on the stock.
Transdigm Group (NYSE:TDG) had its target price boosted by UBS Group AG from $1,738.00 to $1,798.00. They currently have a buy rating on the stock.
Transdigm Group (NYSE:TDG) had its price target boosted by Royal Bank Of Canada from $1,385.00 to $1,400.00. Royal Bank Of Canada currently has a sector perform rating on the stock.
Transdigm Group (NYSE:TDG) had its price target raised by BMO Capital Markets from $1,420.00 to $1,500.00. They currently have an outperform rating on the stock.
Transdigm Group (NYSE:TDG) had its price target trimmed by Stifel Nicolaus from $1,710.00 to $1,650.00. Stifel Nicolaus currently has a buy rating on the stock.
Terns Pharmaceuticals (NASDAQ:TERN) had its target price boosted by Mizuho from $32.00 to $33.00. The firm currently has an outperform rating on the stock.
Tenet Healthcare (NYSE:THC) had its price target raised by Wells Fargo & Company from $238.00 to $252.00. The firm currently has an overweight rating on the stock.
Tenet Healthcare (NYSE:THC) had its target price boosted by JPMorgan Chase & Co. from $200.00 to $230.00. They currently have an overweight rating on the stock.
TreeHouse Foods (NYSE:THS) had its target price boosted by Truist Financial Corporation from $20.00 to $22.50. The firm currently has a hold rating on the stock.
Tencent Music Entertainment Group (NYSE:TME) had its price target lowered by Benchmark Co. from $28.00 to $25.00. The firm currently has a buy rating on the stock.
Toast (NYSE:TOST) had its price target cut by Truist Financial Corporation from $47.00 to $43.00. They currently have a buy rating on the stock.
Targa Resources (NYSE:TRGP) had its price target lowered by The Goldman Sachs Group, Inc. from $189.00 to $188.00. The firm currently has a buy rating on the stock.
Targa Resources (NYSE:TRGP) had its target price lowered by Scotiabank from $199.00 to $198.00. Scotiabank currently has a sector outperform rating on the stock.
TriMas (NASDAQ:TRS) had its price target cut by KeyCorp from $45.00 to $38.00. The firm currently has an overweight rating on the stock.
Tetra Tech (NASDAQ:TTEK) had its price target boosted by Robert W. Baird from $40.00 to $41.00. The firm currently has a neutral rating on the stock.
Touchstone Exploration (LON:TXP) had its target price cut by Canaccord Genuity Group Inc. from GBX 34 to GBX 32. Canaccord Genuity Group Inc. currently has a speculative buy rating on the stock.
United States Antimony (NYSEAMERICAN:UAMY) had its target price boosted by HC Wainwright from $8.50 to $10.25. HC Wainwright currently has a buy rating on the stock.
United Dominion Realty Trust (NYSE:UDR) had its target price cut by Morgan Stanley from $44.50 to $43.50. Morgan Stanley currently has an equal weight rating on the stock.
Universal Health Services (NYSE:UHS) had its target price boosted by Wells Fargo & Company from $249.00 to $259.00. They currently have an overweight rating on the stock.
Venture Global (NYSE:VG) had its target price cut by Scotiabank from $13.00 to $12.00. They currently have a sector perform rating on the stock.
Vista Energy (NYSE:VIST) had its price target boosted by JPMorgan Chase & Co. from $56.00 to $68.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Valens Semiconductor (NYSE:VLN) had its target price cut by Needham & Company LLC from $4.00 to $3.00. The firm currently has a buy rating on the stock.
Volex (LON:VLX) had its price target raised by Jefferies Financial Group Inc. from GBX 430 to GBX 470. The firm currently has a buy rating on the stock.
Vornado Realty Trust (NYSE:VNO) had its price target lowered by Scotiabank from $40.00 to $38.00. They currently have a sector perform rating on the stock.
Ventas (NYSE:VTR) had its price target raised by Scotiabank from $74.00 to $80.00. They currently have a sector perform rating on the stock.
Vizsla Silver (NYSEAMERICAN:VZLA) had its price target raised by Roth Capital from $6.00 to $7.00. Roth Capital currently has a buy rating on the stock.
Wayfair (NYSE:W) had its price target raised by Guggenheim from $120.00 to $125.00. The firm currently has a buy rating on the stock.
Wabtec (NYSE:WAB) had its price target boosted by Bank of America Corporation from $228.00 to $233.00. The firm currently has a buy rating on the stock.
Warner Bros. Discovery (NASDAQ:WBD) had its target price raised by Deutsche Bank Aktiengesellschaft from $23.00 to $26.00. The firm currently has a buy rating on the stock.
WEBTOON Entertainment (NASDAQ:WBTN) had its price target cut by Evercore ISI from $23.00 to $20.00. The firm currently has an outperform rating on the stock.
Welltower (NYSE:WELL) had its price target increased by Scotiabank from $182.00 to $214.00. They currently have a sector outperform rating on the stock.
Western Midstream Partners (NYSE:WES) had its target price increased by Wells Fargo & Company from $38.00 to $40.00. Wells Fargo & Company currently has an equal weight rating on the stock.
Westwater Resources (NASDAQ:WWR) had its target price lowered by HC Wainwright from $2.00 to $1.75. HC Wainwright currently has a buy rating on the stock.
Wynn Resorts (NASDAQ:WYNN) had its price target raised by Mizuho from $126.00 to $131.00. Mizuho currently has an outperform rating on the stock.
Block (NYSE:XYZ) had its price target lowered by Truist Financial Corporation from $74.00 to $67.00. The firm currently has a sell rating on the stock.
Zenas BioPharma (NASDAQ:ZBIO) had its target price raised by Morgan Stanley from $34.00 to $37.00. Morgan Stanley currently has an overweight rating on the stock.
Zscaler (NASDAQ:ZS) had its target price boosted by Morgan Stanley from $320.00 to $335.00. They currently have an overweight rating on the stock.
Receive News & Ratings for Absci Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Absci Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
